Skip to main content
. 2023 Mar 13;11:1149. Originally published 2022 Oct 7. [Version 2] doi: 10.12688/f1000research.124123.2

Table 3. Subgroup analysis depending on aneurysm location.

Anterior circulation aneurysm Posterior circulation aneurysm
Male (n=102) Female (n=169) p Male (n=23) Female (n=49) p
WFNS, n (%)
 1 33 (32.4) 65 (38.5) 0.67 5 (21.7) 13 (26.5) 0.5
 2 20 (19.6) 35 (20.7) 8 (34.8) 8 (16.3)
 3 2 (2) 6 (3.6) 1 (4.3) 4 (8.2)
 4 23 (22.5) 30 (17.8) 5 (21.7) 10 (20.4)
 5 24 (23.5) 33 (19.5) 4 (17.4) 14 (28.6)
Initial GCS median (IQR) 14 (8-15) 14 (8.5-15) 0.99 14 (8-15) 13 (6.5-15) 0.92
GCS on admission median (IQR) 13.5 (3-15) 14 (5-15) 0.67 14 (7-15) 13 (3-15) 0.57
Decrease in vigilance 63 (61.8) 106 (62.7) 0.9 15 (65.2) 32 (65.3) 1
Loss of consciousness 49 (48) 77 (45.6) 0.71 9 (39.1) 25 (51) 0.45
Headache 66 (64.7) 119 (70.4) 0.53 16 (69.6) 38 (77.6) 0.32
Acute onset headache 55 (53.9) 94 (55.6) 0.35 13 (56.5) 30 (61.2) 1
Not acute headache 11 (10.8) 25 (14.8) 0.7 2 (8.7) 9 (18.4) 0.48
Persistent headache 21 (28.4) 42 (24.9) 0.88 6 (26.1) 13 (26.5) 1
Duration of headache in days 3 (3.2) 4.9 (9.2) 2.4 (2.1) 4.1 (3.2)
Nuchal pain 11 (10.8) 28 (16.6) 0.46 7 (30.4) 7 (14.3) 0.11
Exercise-induced headache 9 (8.8) 8 (4.7) 0.11 4 (17.4) 3 (6.1) 0.2
Sexual activity-induced headache 3 (2.9) 4 (2.4) 0.69 1 (4.3) 0 (0) 0.32
Defecation-induced headache 1 (1) 4 (2.4) 0.66 0 (0) 0 (0) 1
Meningism 9 (8.8) 32 (18.9) 0.06 5 (21.7) 7 (16.3) 0.16
Nausea/vomiting 56 (54.9) 97 (57.4) 0.8 9 (39.1) 26 (53.1) 0.31
Observed seizure 17 (16.7) 23 (13.6) 0.49 2 (8.7) 4 (8.2) 1
Possible seizure 36 (35.3) 52 (30.8) 0.5 3 (13) 17 (34.7) 0.09
Seizure (observed or suspected) 50 (48) 72 (42.6) 0.32 6 (26.1) 21 (42.9) 0.12
Focal neurological deficit 15 (14.7) 43 (25.4) 0.11 1 (4.3) 9 (18.4) 0.51
Anisocoria 7 (6.9) 18 (10.7) 0.39 1 (4.3) 8 (16.3) 0.25
Pupils not reactive to light 7 (6.9) 14 (8.3) 0.82 2 (8.7) 6 (12.2) 1
Diplopia 2 (2) 4 (2.4) 1 3 (13) 3 (6.1) 0.38
Oculomotor disorder 4 (3.9) 8 (4.7) 1 1 (4.3) 3 (6.1) 1
Blurred vision 1 (1) 4 (2.4) 1 1 (4.3) 1 (2) 1
Vertigo 9 (8.8) 13 (7.7) 0.47 4 (17.4) 4 (8.2) 0.41
Confusion 25 (24.5) 46 (27.2) 0.75 6 (26.1) 10 (20.4) 0.75
Aphasia 6 (5.9) 10 (5.9) 0.79 0 (0) 2 (4.1) 1
Dysarthria 6 (5.9) 11 (6.5) 1 2 (8.7) 3 (6.1) 0.64
Hemisyndrome/motor deficit 12 (11.8) 23 (13.6) 1 0 (0) 3 (6.1) 0.54
Dys-/hyp-/paresthesia 4 (3.9) 4 (2.4) 0.44 0 (0) 2 (4.1) 0.54
Facial paresis 3 (2.9) 10 (5.9) 0.55 2 (8.7) 1 (2) 0.25
Neglect 1 (1) 1 (0.6) 1 0 (0) 0 (0) 1
Cardiac arrest 0 (0) 4 (2.4) 0.3 4 (17.4) 4 (8.2) 0.26
Hypertensive crisis 16 (15.7) 24 14.2 0.73 4 (17.4) 13 (26.5) 0.55
Ear pressure/pain 0 (0) 1 (0.6) 1 0 (0) 1 (2) 1
Abdominal pain 2 (2) 3 (1.8) 1 0 (0) 2 (4.1) 1
Retrograde amnesia 4 (3.9) 9 (5.3) 1 2 (8.7) 2 (4.1) 0.59
Visual hallucinations 1 (1) 0 (0) 0.33 0 (0) 0 (0) 1
Behavioral change 2 (2) 1 (0.6) 0.26 1 (4.3) 0 (0) 0.33
Tinnitus 0 (0) 1 (0.6) 1 0 (0) 0 (0) 1